CTOs on the Move

Theratechnologies

www.theratech.com

 
Theratechnologies is a biopharmaceutical company focused on the development and commercialization of innovative therapies addressing unmet medical needs.
  • Number of Employees: 100-250
  • Annual Revenue: $10-50 Million
  • www.theratech.com
  • 2015 Peel Street 11th Floor
    Montreal, QC CAN H3A 1T8
  • Phone: 514.336.7800

Executives

Name Title Contact Details

Similar Companies

Integra group

Integra group is a Cincinnati, OH-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Siskin Hospital for Physical Rehabilitation

Siskin Hospital was founded in 1989 as the first freestanding, not-for-profit rehabilitation hospital in Tennessee built specifically for rehabilitation patients. Currently, Siskin Hospital remains as the only not-for-profit rehabilitation hospital in Tennessee, offering an all-inclusive campus, as well as off-campus locations, dedicated to meeting a wide variety of rehabilitation needs. Siskin Hospital offers all private patient rooms and has specialized Inpatient treatment programs in brain injury, amputation, stroke, spinal cord injury, orthopedics, neurological disorders, and major multiple trauma, among other illnesses and disorders.

Avisena

Avisena is one of the leading companies in the Healthcare, Pharmaceuticals, and Biotech sector.

PolyNovo Limited

At PolyNovo we are driven by improving the outcomes of patients through development and provision of the best surgical solutions possible. PolyNovo develops innovative medical devices utilizing the patented bioabsorbable polymer technology Novosorb®. NovoSorb is a family of proprietary medical grade polymers that can be expressed in a variety of physical formats. NovoSorb polymers have advantageous properties such as biocompatibility and design flexibility. These properties underpin novel medical devices designed to support tissue repair, before they biodegrade in situ into biocompatible by-products via established pathways. NovoSorb BTM (Biodegradable Temporizing Matrix) is the first product commercialized by PolyNovo. In 2015, following the FDA 510(K) clearance of BTM, PolyNovo was awarded an $11 million contract and a further $25 million in funding from the US-based Biomedical Advanced Research and Development Authority (BARDA) to complete a trial with BTM for full thickness burns. We have expanded our manufacturing facility and headquarters in Melbourne, Australia, establishing high quality processes, enabling product innovation and preparing for growth.

Neighborcare

Neighborcare Inc. is a Baltimore, MD-based company in the Healthcare, Pharmaceuticals, and Biotech sector.